ANEMIA INSIGHTS Trademark
Trademark Overview
On Monday, May 5, 2025, a trademark application was filed for ANEMIA INSIGHTS with the United States Patent and Trademark Office. The USPTO has given the ANEMIA INSIGHTS trademark a serial number of 99169401. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 5, 2025. This trademark is owned by FRESENIUS MEDICAL CARE HOLDINGS, INC.. The ANEMIA INSIGHTS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:
Biofeedback sensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
Cloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
General Information
| Serial Number | 99169401 |
| Word Mark | ANEMIA INSIGHTS |
| Filing Date | Monday, May 5, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Monday, May 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Biofeedback sensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages |
| Goods and Services | Cloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 5, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 5, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | FRESENIUS MEDICAL CARE HOLDINGS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | WALTHAM, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Monday, May 5, 2025 | NEW APPLICATION ENTERED |
| Monday, May 5, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 5, 2025 | APPLICATION FILING RECEIPT MAILED |
